{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:59:48Z","timestamp":1780700388579,"version":"3.54.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Infiltrative cardiomyopathies, a subset of restrictive cardiomyopathies, are rare but clinically essential disorders often lead to heart failure, which is a major global health issue. Although interest in these conditions is growing, they remain poorly understood due to their low occurrence, vague clinical signs, and frequent underreporting. Advances in diagnosis have been made through multimodal imaging techniques\u2014including cardiac magnetic resonance, nuclear imaging, and computed tomography\u2014as well as genetic testing and new biomarkers for amyloidosis. However, a universal biomarker that applies across the entire range of infiltrative cardiomyopathies has yet to be identified. This review discusses albumin, a vital regulator of physiological balance, as a promising biomarker candidate. In this narrative review, we explore disease mechanisms, identify knowledge gaps in research, and suggest new connections to direct future studies and enhance diagnostic accuracy.<\/jats:p>","DOI":"10.1097\/crd.0000000000001283","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:00:45Z","timestamp":1777561245000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Low Albumin, Heavy Hearts: Role of Hypoalbuminemia in Infiltrative Cardiomyopathies: A Narrative Review"],"prefix":"10.1097","author":[{"given":"Roshni Riaz","family":"Memon","sequence":"first","affiliation":[{"name":"Internal Medicine, Ziauddin Medical College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niharika","family":"Ikkurthy","sequence":"additional","affiliation":[{"name":"Internal Medicine, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Muzammil","family":"Jumani","sequence":"additional","affiliation":[{"name":"Internal Medicine, Lake Erie College of Osteopathic Medicine, Elmira, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Fazal","family":"Rizvi","sequence":"additional","affiliation":[{"name":"Internal Medicine, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Kumar","sequence":"additional","affiliation":[{"name":"Critical Care Medicine, George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/14796678.2024.2393031","article-title":"Transthyretin amyloid cardiomyopathy in severe aortic stenosis submitted to valve replacement: a multicenter study.","volume":"20","author":"Pereira","year":"2024","journal-title":"Future Cardiol"},{"key":"R3-20260605","first-page":"29","article-title":"Infiltrative cardiomyopathies.","volume":"9","author":"Bejar","year":"2015","journal-title":"Clin Med Insights Cardiol"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"7722","DOI":"10.3390\/ijms22147722","article-title":"Cardiomyopathies: an overview.","volume":"22","author":"Ciarambino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology.","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure.","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/ehf2.14320","article-title":"The burden of heart failure in cardiac intensive care unit: a prospective 7 years analysis.","volume":"10","author":"Grupper","year":"2023","journal-title":"ESC Heart Fail"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1093\/eurheartj\/ehad626","article-title":"A 20-year population study of peripartum cardiomyopathy.","volume":"44","author":"Jackson","year":"2023","journal-title":"Eur Heart J"},{"key":"R10-20260605","first-page":"51","article-title":"The role of serum albumin in critical care: clinical outcomes and implications for therapy.","volume":"11","author":"Mukherjee","year":"2025","journal-title":"J Contemporary Clin Prac"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ejhf.3363","article-title":"Hypoalbuminaemia and heart failure: a practical review of current evidence.","volume":"27","author":"Biancucci","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ancard.2020.07.012","article-title":"Serum albumin and cardiovascular disease: state-of-the-art review.","volume":"69","author":"Arques","year":"2020","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCRESAHA.117.309711","article-title":"Classification, epidemiology, and global burden of cardiomyopathies.","volume":"121","author":"McKenna","year":"2017","journal-title":"Circ Res"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"101819","DOI":"10.1016\/j.cpcardiol.2023.101819","article-title":"Trends in the prevalence of infiltrative cardiomyopathy among patients with in-hospital cardiac arrest.","volume":"48","author":"Nandy","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pcad.2007.10.003","article-title":"Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis.","volume":"51","author":"Lubitz","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"R18-20260605","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pcad.2019.05.002","article-title":"Sudden cardiac death in nonischemic cardiomyopathy.","volume":"62","author":"Kadakia","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"R19-20260605","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31083\/j.rcm.2020.02.65","article-title":"Clinical evaluation of infiltrative cardiomyopathies resulting in heart failure with preserved ejection fraction.","volume":"21","author":"Madan","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/jce.16487","article-title":"Catheter ablation of atrial fibrillation in infiltrative cardiomyopathies: a narrative review.","volume":"36","author":"Satish","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R21-20260605","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/clc.22706","article-title":"Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: insights from the PROLONG study.","volume":"40","author":"Duncker","year":"2017","journal-title":"Clin Cardiol"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"e70103","DOI":"10.1111\/echo.70103","article-title":"Uncommon causes of pulmonary hypertension with associated cardiomyopathy: computed tomography and magnetic resonance imaging of cardiothoracic manifestations.","volume":"42","author":"Muscogiuri","year":"2025","journal-title":"Echocardiogr"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"e231910","DOI":"10.1136\/bcr-2019-231910","article-title":"Cardiac amyloidosis presenting with recurrent ischaemic strokes.","volume":"13","author":"Suleiman","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R24-20260605","first-page":"32","article-title":"Cardiomyopathies.","volume":"90","author":"Precone","year":"2019","journal-title":"Acta Biomed"},{"key":"R25-20260605","doi-asserted-by":"crossref","first-page":"e005618","DOI":"10.1161\/CIRCOUTCOMES.119.005618","article-title":"Epidemiology of shock in contemporary cardiac intensive care units: data from the critical care cardiology trials network registry.","volume":"12","author":"Berg","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R26-20260605","doi-asserted-by":"crossref","first-page":"368504241274023","DOI":"10.1177\/00368504241274023","article-title":"The role of serum albumin in critical illness, predicting poor outcomes, and exploring the therapeutic potential of albumin supplementation.","volume":"107","author":"Rabi","year":"2024","journal-title":"Sci Prog"},{"key":"R27-20260605","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R28-20260605","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jpen.1451","article-title":"Hypoalbuminemia: pathogenesis and clinical significance.","volume":"43","author":"Soeters","year":"2019","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R29-20260605","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejim.2022.05.004","article-title":"Low serum albumin: a neglected predictor in patients with cardiovascular disease.","volume":"102","author":"Manolis","year":"2022","journal-title":"Eur J Intern Med"},{"key":"R30-20260605","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/ckj\/sfab194","article-title":"Albumin is an interface between blood plasma and cell membrane, and not just a sponge.","volume":"15","author":"Van De Wouw","year":"2022","journal-title":"Clin Kidney J"},{"key":"R31-20260605","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.cjco.2021.06.010","article-title":"From hip to heart: a comprehensive evaluation of an infiltrative cardiomyopathy.","volume":"3","author":"Singh","year":"2021","journal-title":"CJC Open"},{"key":"R32-20260605","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/CLEP.S45305","article-title":"Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs.","volume":"199","author":"Ording","year":"2013","journal-title":"CLEP"},{"key":"R33-20260605","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2009.12.040","article-title":"Casaclang -verzosa grace. infiltrative cardiovascular diseases.","volume":"55","author":"Seward","year":"2010","journal-title":"JACC"},{"key":"R34-20260605","doi-asserted-by":"crossref","first-page":"e000081","DOI":"10.1161\/HCI.0000000000000081","article-title":"State-of-the-Art imaging of infiltrative cardiomyopathies: a scientific statement from the American Heart Association.","volume":"16","author":"Kottam","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"R35-20260605","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12350-018-1356-y","article-title":"Emerging imaging targets for infiltrative cardiomyopathy: inflammation and fibrosis.","volume":"26","author":"Bengel","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"R36-20260605","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10741-025-10502-5","article-title":"Emerging, novel gene-modulating therapies for transthyretin amyloid cardiomyopathy.","volume":"30","author":"Ang","year":"2025","journal-title":"Heart Fail Rev"},{"key":"R37-20260605","doi-asserted-by":"crossref","first-page":"108758","DOI":"10.1016\/j.pharmthera.2024.108758","article-title":"Optimizing drug therapies in cardiac amyloidosis.","volume":"265","author":"Younis","year":"2025","journal-title":"Pharmacol Ther"},{"key":"R39-20260605","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40364-017-0111-x","article-title":"Critical appraisal of the role of serum albumin in cardiovascular disease.","volume":"5","author":"Chien","year":"2017","journal-title":"Biomark Res"},{"key":"R41-20260605","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/ATVBAHA.119.313681","article-title":"Plasma albumin and incident cardiovascular disease: results from the CGPS and an updated meta-analysis.","volume":"40","author":"Ronit","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R42-20260605","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1134\/S002209302106020X","article-title":"Integrative role of albumin: evolutionary, biochemical and pathophysiological aspects.","volume":"57","author":"Belinskaia","year":"2021","journal-title":"J Evol Biochem Physiol"},{"key":"R43-20260605","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cardfail.2011.02.010","article-title":"Human serum albumin in the clinical syndrome of heart failure.","volume":"17","author":"Arques","year":"2011","journal-title":"J Card Fail"},{"key":"R44-20260605","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.seminoncol.2013.01.009","article-title":"Infiltrative cardiomyopathy and pericardial disease.","volume":"40","author":"Yusuf","year":"2013","journal-title":"Semin Oncol"},{"key":"R45-20260605","first-page":"79","article-title":"Severe cardiomyopathy as the isolated presenting feature in an adult with late-onset Pompe disease: a case report.","volume":"31","author":"Mori","year":"2017","journal-title":"JIMD Rep"},{"key":"R46-20260605","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/IJCA.IJCA_49_19","article-title":"C-reactive protein\/albumin ratio designates advanced heart failure among outpatients with heart failure.","volume":"6","author":"Yucel","year":"2020","journal-title":"Int J Cardiovas Acad"},{"key":"R47-20260605","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/00033197221120135","article-title":"High C-reactive protein\/low serum albumin: a hidden villain in cardiovascular disease.","volume":"73","author":"Manolis","year":"2022","journal-title":"Angiology"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:00:12Z","timestamp":1780696812000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001283","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}